{
  "generated_at_pt": "01-27-2026 20:48",
  "buys": [
    {
      "ticker": "ABT",
      "company": "Abbott Laboratories",
      "signal": "BUY",
      "score": 25.75,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 108.27,
      "price_str": "108.27",
      "rsi": 20.765000335678323,
      "pe": 29.104837,
      "market_cap": 188439494656.0,
      "pct_drop": 0.45968250298579255,
      "rsi_str": "20.8",
      "pe_str": "29.1",
      "market_cap_str": "188.4B",
      "dma200": 129.43255004882812,
      "dma50": 124.29779937744141,
      "dma200_str": "129.4",
      "dma50_str": "124.3",
      "trend_rationale": "Strong Bearish Trend (ADX: 25.0)",
      "trend_dir": "bearish",
      "put": {
        "strike": 70.0,
        "expiration": "Feb 20, 2026",
        "exp_type": "MONTHLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 0.38,
        "delta_percent": 35.3468181398356,
        "premium_percent": 0.3509744158123211,
        "metric_sum": 35.69779255564792
      },
      "news_summary": "GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window.",
      "news": [
        {
          "headline": "GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window",
          "url": "https://247wallst.com/investing/2026/01/27/gamestop-ceo-picks-up-1m-shares-and-other-insiders-return-to-the-buy-window/",
          "sentiment": -0.125,
          "summary": "",
          "article_text": "Also, beneficial owners continue to build their stakes in Mission Produce Inc. ( NASDAQ: AVO ), Under Armour Inc. ( NYSE: UAA ), and W.R. Berkley Corp. ( NYSE: WRB ).\n\nThe CEO of GameStop Corp. ( NYSE: GME ) showed some love for the beleaguered retailer by purchasing a million shares.\n\nThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.\n\nInsider buying may have slowed as earnings-reporting ramps up, yet th"
        },
        {
          "headline": "Optimism around Abbott Laboratories (NYSE:ABT) delivering new earnings growth may be shrinking as stock declines 11% this past week",
          "url": "https://finance.yahoo.com/news/optimism-around-abbott-laboratories-nyse-110023246.html",
          "sentiment": -0.05681818181818182,
          "summary": "",
          "article_text": "The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. That downside risk was realized by Abbott Laboratories (NYSE:ABT) shareholders over the last year, as the share price declined 16%. That falls noticeably short of the market return of around 17%. At least the damage isn't so bad if you look at the last three years, since the stock is down 0.9% in that tim"
        },
        {
          "headline": "Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact",
          "url": "https://finance.yahoo.com/news/evercore-isi-says-abbott-abt-214325952.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026.\n\nEvercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact\n\nCourtesy of Abbott Labs\n\nOn January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious outlook for the second half, but said the bigger picture has no"
        },
        {
          "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-140003240.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.\n\nShares of this maker of infant formula, medical devices and drugs have returned -14% over the past month versus the Zacks S&P 500 composite's +0.2% change. The Zacks Medical - Products industry, to which Abbott belongs, has lost 8% over this period. Now the key question is: Where could the stock be headed in the"
        },
        {
          "headline": "3 Reasons to Buy This Dividend King After Its Steep Sell-Off",
          "url": "https://www.fool.com/investing/2026/01/26/3-reasons-to-buy-this-dividend-king-after-its-stee/",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Investors' reaction to this Dividend King's Q4 revenue miss was overdone.\n\nAbbott Laboratories (ABT 0.46%) announced its 2025 fourth-quarter and full-year results before the market opened on Thursday, Jan. 22, 2026. And its shares promptly plunged nearly 10%. As you probably figured out from that brief overview, investors didn't like the healthcare giant's Q4 update.\n\nHowever, Abbott has been a favorite for many income investors. The company is a member of the Dividend Kings, an elite group of s"
        }
      ]
    },
    {
      "ticker": "HUM",
      "company": "Humana Inc.",
      "signal": "BUY",
      "score": 31.25,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 207.93,
      "price_str": "207.93",
      "rsi": 22.24964943286281,
      "pe": 19.45089,
      "market_cap": 25008379904.0,
      "pct_drop": 21.128097656248187,
      "rsi_str": "22.2",
      "pe_str": "19.5",
      "market_cap_str": "25.0B",
      "dma200": 258.8455007171631,
      "dma50": 256.4950012207031,
      "dma200_str": "258.8",
      "dma50_str": "256.5",
      "trend_rationale": "Strong Bearish Trend (ADX: 25.0)",
      "trend_dir": "bearish",
      "put": {
        "strike": 185.0,
        "expiration": "Feb 20, 2026",
        "exp_type": "MONTHLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 4.47,
        "delta_percent": 11.02774972346463,
        "premium_percent": 2.1497619391141245,
        "metric_sum": 13.177511662578755
      },
      "news_summary": "UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates.",
      "news": [
        {
          "headline": "UnitedHealth stock plunges, leads insurers lower after Trump Medicare spending plan surprise",
          "url": "https://finance.yahoo.com/news/unitedhealth-stock-plunges-leads-insurers-lower-after-trump-medicare-spending-plan-surprise-164253590.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "The health insurance sector saw a deep sell-off Tuesday, led by a plunge in UnitedHealth Group (UNH) shares, as the Trump administration proposed a lower-than-expected increase to 2027 Medicare Advantage plans.\n\nIn a report published Monday night by the Centers for Medicare & Medicaid Services (CMS), the administration proposed that payment rates for Medicare Advantage plans (private insurance plans) will rise by just 0.09% in 2027. Analysts were expecting an increase of as much as 6%.\n\nUnitedHe"
        },
        {
          "headline": "UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates",
          "url": "https://finance.yahoo.com/news/unitedhealth-humana-cvs-shares-crushed-043108013.html",
          "sentiment": -0.1,
          "summary": "",
          "article_text": "Health insurer stocks are tumbling after the market close on Monday following a report indicating the Trump administration will propose essentially unchanged rates for Medicare insurers next year.\n\nRoughly Flat Rates Report Hits Medicare Insurers\n\nThe Trump administration reportedly plans to propose “roughly flat” rates for Medicare insurers in 2027, setting up payments to plans to increase by approximately 0.09% next year, according to The Wall Street Journal.\n\nDon't Miss:\n\nThe report, citing o"
        },
        {
          "headline": "S&P 500 marks closing record as corporate earnings roll in",
          "url": "https://finance.yahoo.com/video/p-500-marks-closing-record-000615134.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "How to get approved"
        },
        {
          "headline": "Heard on the Street Recap: Medicare Disadvantage",
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-27-2026/card/heard-on-the-street-recap-medicare-disadvantage-6uKXRcQTZjE2oGPWnBWE?siteid=yhoof2&yptr=yahoo",
          "sentiment": 0.0,
          "summary": "The health-insurance sector crumbled on Tuesday on news the Trump administration wants to hold Medicare rates almost flat next year.  Shares in Humana closed down 21%, while UnitedHealth plunged 20% and CVS declined 14%.  The Wall Street Journal reported that the Centers for Medicare and Medicaid Services proposed to hold payment rates to an average .09% increase next year, far below what the companies and Wall Street had expected.",
          "article_text": ""
        },
        {
          "headline": "Health Insurers in Shock After Medicare Holds Line on 2027 Payments",
          "url": "https://www.wsj.com/health/healthcare/shock-and-dismay-among-health-insurers-after-medicare-holds-line-on-2027-payments-3c5bb085?siteid=yhoof2&yptr=yahoo",
          "sentiment": 0.0,
          "summary": "Big companies lost $96 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year.",
          "article_text": ""
        }
      ]
    },
    {
      "ticker": "MA",
      "company": "Mastercard Incorporated",
      "signal": "BUY",
      "score": 37.5,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 520.41,
      "price_str": "520.41",
      "rsi": 29.893460607628242,
      "pe": 33.2318,
      "market_cap": 470456762368.0,
      "pct_drop": 1.3178825744485243,
      "rsi_str": "29.9",
      "pe_str": "33.2",
      "market_cap_str": "470.5B",
      "dma200": 562.8714488220215,
      "dma50": 553.1315966796875,
      "dma200_str": "562.9",
      "dma50_str": "553.1",
      "trend_rationale": "Strong Bearish Trend (ADX: 31.5)",
      "trend_dir": "bearish",
      "put": {
        "strike": 460.0,
        "expiration": "Mar 06, 2026",
        "exp_type": "WEEKLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 2.95,
        "delta_percent": 11.608155108472161,
        "premium_percent": 0.566860744413059,
        "metric_sum": 12.17501585288522
      },
      "news_summary": "Earnings live: UnitedHealth stock falls 19%, American Airlines slides, Texas Instruments pops, Logitech edges higher.",
      "news": [
        {
          "headline": "Earnings live: UnitedHealth stock falls 19%, American Airlines slides, Texas Instruments pops, Logitech edges higher",
          "url": "https://finance.yahoo.com/news/live/earnings-live-unitedhealth-stock-falls-19-american-airlines-slides-texas-instruments-pops-logitech-edges-higher-213941564.html",
          "sentiment": 0.12878787878787878,
          "summary": "",
          "article_text": "The fourth quarter earnings season kicks into high gear this week, with Big Tech results from Microsoft (MSFT), Meta (META), Tesla (TSLA), and Apple (AAPL) headlining the earnings calendar.\n\nAn optimistic consensus is forming: As of Jan. 23, 13% of S&P 500 (^GSPC) companies have reported fourth quarter results, according to FactSet data, and Wall Street analysts estimate an 8.2% increase in earnings per share for the fourth quarter. If that rate holds, it would represent the 10th consecutive qua"
        },
        {
          "headline": "Mastercard (MA) To Report Earnings Tomorrow: Here Is What To Expect",
          "url": "https://finance.yahoo.com/news/mastercard-ma-report-earnings-tomorrow-030510529.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Global payments technology company Mastercard (NYSE:MA) will be reporting results this Thursday before market hours. Here’s what investors should know.\n\nMastercard beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $8.60 billion, up 16.7% year on year. It was a mixed quarter for the company, with but .\n\nIs Mastercard a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.\n\nThis quarter, analysts are expecting Mastercard’s re"
        },
        {
          "headline": "Top Research Reports for Broadcom, Oracle & Mastercard",
          "url": "https://finance.yahoo.com/news/top-research-reports-broadcom-oracle-214000993.html",
          "sentiment": 0.5,
          "summary": "",
          "article_text": "Tuesday, January 27, 2026\n\n\n\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Oracle Corp. (ORCL) and Mastercard Inc. (MA), as well as two micro-cap stocks Geospace Technologies Corp. (GEOS) and Gencor Industries, Inc. (GENC). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its ty"
        },
        {
          "headline": "Jim Cramer Discusses Mastercard (MA) & Trump Credit Card Cap",
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-mastercard-ma-174915771.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "We recently published 13 Stocks Jim Cramer Commented On. Mastercard Incorporated (NYSE:MA) is one of the stocks Jim Cramer commanded on.\n\nPayment processor Mastercard Incorporated (NYSE:MA)’s shares are down by 4% over the past year and by 6.8% year-to-date. As per The Fly, Compass Point upgraded the shares to Buy from Neutral and raised the share price target to $735 from $620 in mid-January. The firm pointed out that Mastercard Incorporated (NYSE:MA)’s sector was finding a bottom that could oc"
        },
        {
          "headline": "Is Mastercard Stock a Smart Bet Ahead of Q4 Earnings? Key Estimates",
          "url": "https://finance.yahoo.com/news/mastercard-stock-smart-bet-ahead-165400144.html",
          "sentiment": 0.10714285714285714,
          "summary": "",
          "article_text": "Payments giant Mastercard Incorporated MA is set to report fourth-quarter 2025 results on Jan. 29, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $4.20 per shareon revenues of $8.74 billion.\n\nThe fourth-quarter earnings estimate witnessed one upward revision and two downward movements over the past month. Yet, the bottom-line projection indicates an increase of 10% from the year-ago reported number. The Zacks Consensus"
        }
      ]
    }
  ],
  "sells": [],
  "all": [
    {
      "ticker": "ABT",
      "company": "Abbott Laboratories",
      "signal": "BUY",
      "score": 25.75,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 108.27,
      "price_str": "108.27",
      "rsi": 20.765000335678323,
      "pe": 29.104837,
      "market_cap": 188439494656.0,
      "pct_drop": 0.45968250298579255,
      "rsi_str": "20.8",
      "pe_str": "29.1",
      "market_cap_str": "188.4B",
      "dma200": 129.43255004882812,
      "dma50": 124.29779937744141,
      "dma200_str": "129.4",
      "dma50_str": "124.3",
      "trend_rationale": "Strong Bearish Trend (ADX: 25.0)",
      "trend_dir": "bearish",
      "put": {
        "strike": 70.0,
        "expiration": "Feb 20, 2026",
        "exp_type": "MONTHLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 0.38,
        "delta_percent": 35.3468181398356,
        "premium_percent": 0.3509744158123211,
        "metric_sum": 35.69779255564792
      },
      "news_summary": "GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window.",
      "news": [
        {
          "headline": "GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window",
          "url": "https://247wallst.com/investing/2026/01/27/gamestop-ceo-picks-up-1m-shares-and-other-insiders-return-to-the-buy-window/",
          "sentiment": -0.125,
          "summary": "",
          "article_text": "Also, beneficial owners continue to build their stakes in Mission Produce Inc. ( NASDAQ: AVO ), Under Armour Inc. ( NYSE: UAA ), and W.R. Berkley Corp. ( NYSE: WRB ).\n\nThe CEO of GameStop Corp. ( NYSE: GME ) showed some love for the beleaguered retailer by purchasing a million shares.\n\nThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.\n\nInsider buying may have slowed as earnings-reporting ramps up, yet th"
        },
        {
          "headline": "Optimism around Abbott Laboratories (NYSE:ABT) delivering new earnings growth may be shrinking as stock declines 11% this past week",
          "url": "https://finance.yahoo.com/news/optimism-around-abbott-laboratories-nyse-110023246.html",
          "sentiment": -0.05681818181818182,
          "summary": "",
          "article_text": "The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. That downside risk was realized by Abbott Laboratories (NYSE:ABT) shareholders over the last year, as the share price declined 16%. That falls noticeably short of the market return of around 17%. At least the damage isn't so bad if you look at the last three years, since the stock is down 0.9% in that tim"
        },
        {
          "headline": "Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact",
          "url": "https://finance.yahoo.com/news/evercore-isi-says-abbott-abt-214325952.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026.\n\nEvercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact\n\nCourtesy of Abbott Labs\n\nOn January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious outlook for the second half, but said the bigger picture has no"
        },
        {
          "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-140003240.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.\n\nShares of this maker of infant formula, medical devices and drugs have returned -14% over the past month versus the Zacks S&P 500 composite's +0.2% change. The Zacks Medical - Products industry, to which Abbott belongs, has lost 8% over this period. Now the key question is: Where could the stock be headed in the"
        },
        {
          "headline": "3 Reasons to Buy This Dividend King After Its Steep Sell-Off",
          "url": "https://www.fool.com/investing/2026/01/26/3-reasons-to-buy-this-dividend-king-after-its-stee/",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Investors' reaction to this Dividend King's Q4 revenue miss was overdone.\n\nAbbott Laboratories (ABT 0.46%) announced its 2025 fourth-quarter and full-year results before the market opened on Thursday, Jan. 22, 2026. And its shares promptly plunged nearly 10%. As you probably figured out from that brief overview, investors didn't like the healthcare giant's Q4 update.\n\nHowever, Abbott has been a favorite for many income investors. The company is a member of the Dividend Kings, an elite group of s"
        }
      ]
    },
    {
      "ticker": "BRO",
      "company": "Brown & Brown, Inc.",
      "signal": null,
      "score": 22.0,
      "why": "Below slow SMA • RSI 32 • Bearish MACD",
      "price": 74.12,
      "price_str": "74.12",
      "rsi": 31.559717694110574,
      "pe": 23.455696,
      "market_cap": 25306109952.0,
      "pct_drop": 6.907815318830962,
      "rsi_str": "31.6",
      "pe_str": "23.5",
      "market_cap_str": "25.3B",
      "dma200": 95.29619979858398,
      "dma50": 79.7302001953125,
      "dma200_str": "95.3",
      "dma50_str": "79.7",
      "trend_rationale": "Strong Bearish Trend (ADX: 28.7)",
      "trend_dir": "bearish"
    },
    {
      "ticker": "HUM",
      "company": "Humana Inc.",
      "signal": "BUY",
      "score": 31.25,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 207.93,
      "price_str": "207.93",
      "rsi": 22.24964943286281,
      "pe": 19.45089,
      "market_cap": 25008379904.0,
      "pct_drop": 21.128097656248187,
      "rsi_str": "22.2",
      "pe_str": "19.5",
      "market_cap_str": "25.0B",
      "dma200": 258.8455007171631,
      "dma50": 256.4950012207031,
      "dma200_str": "258.8",
      "dma50_str": "256.5",
      "trend_rationale": "Strong Bearish Trend (ADX: 25.0)",
      "trend_dir": "bearish",
      "put": {
        "strike": 185.0,
        "expiration": "Feb 20, 2026",
        "exp_type": "MONTHLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 4.47,
        "delta_percent": 11.02774972346463,
        "premium_percent": 2.1497619391141245,
        "metric_sum": 13.177511662578755
      },
      "news_summary": "UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates.",
      "news": [
        {
          "headline": "UnitedHealth stock plunges, leads insurers lower after Trump Medicare spending plan surprise",
          "url": "https://finance.yahoo.com/news/unitedhealth-stock-plunges-leads-insurers-lower-after-trump-medicare-spending-plan-surprise-164253590.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "The health insurance sector saw a deep sell-off Tuesday, led by a plunge in UnitedHealth Group (UNH) shares, as the Trump administration proposed a lower-than-expected increase to 2027 Medicare Advantage plans.\n\nIn a report published Monday night by the Centers for Medicare & Medicaid Services (CMS), the administration proposed that payment rates for Medicare Advantage plans (private insurance plans) will rise by just 0.09% in 2027. Analysts were expecting an increase of as much as 6%.\n\nUnitedHe"
        },
        {
          "headline": "UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates",
          "url": "https://finance.yahoo.com/news/unitedhealth-humana-cvs-shares-crushed-043108013.html",
          "sentiment": -0.1,
          "summary": "",
          "article_text": "Health insurer stocks are tumbling after the market close on Monday following a report indicating the Trump administration will propose essentially unchanged rates for Medicare insurers next year.\n\nRoughly Flat Rates Report Hits Medicare Insurers\n\nThe Trump administration reportedly plans to propose “roughly flat” rates for Medicare insurers in 2027, setting up payments to plans to increase by approximately 0.09% next year, according to The Wall Street Journal.\n\nDon't Miss:\n\nThe report, citing o"
        },
        {
          "headline": "S&P 500 marks closing record as corporate earnings roll in",
          "url": "https://finance.yahoo.com/video/p-500-marks-closing-record-000615134.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "How to get approved"
        },
        {
          "headline": "Heard on the Street Recap: Medicare Disadvantage",
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-27-2026/card/heard-on-the-street-recap-medicare-disadvantage-6uKXRcQTZjE2oGPWnBWE?siteid=yhoof2&yptr=yahoo",
          "sentiment": 0.0,
          "summary": "The health-insurance sector crumbled on Tuesday on news the Trump administration wants to hold Medicare rates almost flat next year.  Shares in Humana closed down 21%, while UnitedHealth plunged 20% and CVS declined 14%.  The Wall Street Journal reported that the Centers for Medicare and Medicaid Services proposed to hold payment rates to an average .09% increase next year, far below what the companies and Wall Street had expected.",
          "article_text": ""
        },
        {
          "headline": "Health Insurers in Shock After Medicare Holds Line on 2027 Payments",
          "url": "https://www.wsj.com/health/healthcare/shock-and-dismay-among-health-insurers-after-medicare-holds-line-on-2027-payments-3c5bb085?siteid=yhoof2&yptr=yahoo",
          "sentiment": 0.0,
          "summary": "Big companies lost $96 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year.",
          "article_text": ""
        }
      ]
    },
    {
      "ticker": "MA",
      "company": "Mastercard Incorporated",
      "signal": "BUY",
      "score": 37.5,
      "why": "Below slow SMA • Oversold • Bearish MACD",
      "price": 520.41,
      "price_str": "520.41",
      "rsi": 29.893460607628242,
      "pe": 33.2318,
      "market_cap": 470456762368.0,
      "pct_drop": 1.3178825744485243,
      "rsi_str": "29.9",
      "pe_str": "33.2",
      "market_cap_str": "470.5B",
      "dma200": 562.8714488220215,
      "dma50": 553.1315966796875,
      "dma200_str": "562.9",
      "dma50_str": "553.1",
      "trend_rationale": "Strong Bearish Trend (ADX: 31.5)",
      "trend_dir": "bearish",
      "put": {
        "strike": 460.0,
        "expiration": "Mar 06, 2026",
        "exp_type": "WEEKLY",
        "weekly_available": true,
        "monthly_available": true,
        "premium": 2.95,
        "delta_percent": 11.608155108472161,
        "premium_percent": 0.566860744413059,
        "metric_sum": 12.17501585288522
      },
      "news_summary": "Earnings live: UnitedHealth stock falls 19%, American Airlines slides, Texas Instruments pops, Logitech edges higher.",
      "news": [
        {
          "headline": "Earnings live: UnitedHealth stock falls 19%, American Airlines slides, Texas Instruments pops, Logitech edges higher",
          "url": "https://finance.yahoo.com/news/live/earnings-live-unitedhealth-stock-falls-19-american-airlines-slides-texas-instruments-pops-logitech-edges-higher-213941564.html",
          "sentiment": 0.12878787878787878,
          "summary": "",
          "article_text": "The fourth quarter earnings season kicks into high gear this week, with Big Tech results from Microsoft (MSFT), Meta (META), Tesla (TSLA), and Apple (AAPL) headlining the earnings calendar.\n\nAn optimistic consensus is forming: As of Jan. 23, 13% of S&P 500 (^GSPC) companies have reported fourth quarter results, according to FactSet data, and Wall Street analysts estimate an 8.2% increase in earnings per share for the fourth quarter. If that rate holds, it would represent the 10th consecutive qua"
        },
        {
          "headline": "Mastercard (MA) To Report Earnings Tomorrow: Here Is What To Expect",
          "url": "https://finance.yahoo.com/news/mastercard-ma-report-earnings-tomorrow-030510529.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "Global payments technology company Mastercard (NYSE:MA) will be reporting results this Thursday before market hours. Here’s what investors should know.\n\nMastercard beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $8.60 billion, up 16.7% year on year. It was a mixed quarter for the company, with but .\n\nIs Mastercard a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.\n\nThis quarter, analysts are expecting Mastercard’s re"
        },
        {
          "headline": "Top Research Reports for Broadcom, Oracle & Mastercard",
          "url": "https://finance.yahoo.com/news/top-research-reports-broadcom-oracle-214000993.html",
          "sentiment": 0.5,
          "summary": "",
          "article_text": "Tuesday, January 27, 2026\n\n\n\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Oracle Corp. (ORCL) and Mastercard Inc. (MA), as well as two micro-cap stocks Geospace Technologies Corp. (GEOS) and Gencor Industries, Inc. (GENC). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its ty"
        },
        {
          "headline": "Jim Cramer Discusses Mastercard (MA) & Trump Credit Card Cap",
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-mastercard-ma-174915771.html",
          "sentiment": 0.0,
          "summary": "",
          "article_text": "We recently published 13 Stocks Jim Cramer Commented On. Mastercard Incorporated (NYSE:MA) is one of the stocks Jim Cramer commanded on.\n\nPayment processor Mastercard Incorporated (NYSE:MA)’s shares are down by 4% over the past year and by 6.8% year-to-date. As per The Fly, Compass Point upgraded the shares to Buy from Neutral and raised the share price target to $735 from $620 in mid-January. The firm pointed out that Mastercard Incorporated (NYSE:MA)’s sector was finding a bottom that could oc"
        },
        {
          "headline": "Is Mastercard Stock a Smart Bet Ahead of Q4 Earnings? Key Estimates",
          "url": "https://finance.yahoo.com/news/mastercard-stock-smart-bet-ahead-165400144.html",
          "sentiment": 0.10714285714285714,
          "summary": "",
          "article_text": "Payments giant Mastercard Incorporated MA is set to report fourth-quarter 2025 results on Jan. 29, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $4.20 per shareon revenues of $8.74 billion.\n\nThe fourth-quarter earnings estimate witnessed one upward revision and two downward movements over the past month. Yet, the bottom-line projection indicates an increase of 10% from the year-ago reported number. The Zacks Consensus"
        }
      ]
    }
  ]
}